Role of the US Veterans Health Administration Clinical Pharmacy Specialist Provider: Shaping the Future of Comprehensive Medication Management

Abstract

-

Trends in Health Service Utilization After Enrollment in an Interdisciplinary Primary Care Clinic for Veterans with Addiction, Social Determinants of Health, or Other Vulnerabilities

“… 23 Briefly, VIP is a unique staffing model led by dedicated (i.e., not shared with other teams) primary care providers with certification in addiction medicine ( n =3), an x-waivered internist ( n =1), and nurse care manager ( n =1). VIP also includes 2 mental health pharmacists 24 specializing in SUD treatment, a mental health nurse, and a social worker. During the study period, five prescriber-led teams had a nurse care manager and mental health pharmacist co-located and integrated within every aspect of care, where appropriate.…”

WVSUD-PACT: a Primary-Care-Based Substance Use Disorder Team for Women Veterans

“…Our model also builds on VHA experience utilizing CPSs to improve outcomes for chronic diseases. 38 Outside VHA, pharmacist-led interventions have been shown to improve adherence to psychiatric medications 39 and to increase MAUD within addiction treatment programs. 40 Within VHA, efforts to expand CPS practice to include management of SUDs have had encouraging results.…”

Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders

“…We calculated the total time spent per patient by multiplying the number of encounters with the median of the time range per encounter type. We also counted medication interventions recorded in the “PharmD Tool.” 31,32 As described elsewhere, 31 the PharmD Tool is a data collection instrument within the VA’s EHR that documents pharmacist clinical activity by type of intervention (eg, medication initiation) and condition (eg, OUD). Other patient care activity variables extracted from the EHR included number of consultation requests, referrals, naloxone kit orders, and lab orders placed by CPPs in 2019.…”